Brussels fines Teva 462.6 million for hindering competition in the multiple sclerosis market
The European Commission has imposed a fine of 462.6 million to the pharmaceutical company Teva for hindering competition in the ...
The European Commission has imposed a fine of 462.6 million to the pharmaceutical company Teva for hindering competition in the ...
The European Commission announced this Thursday a fine of 462.6 million euros to the pharmaceutical company Teva for abuse its ...